Article

SGLT2 Inhibitors and Potential Applications in Treating Metabolic Syndrome

2022-04-21

Abstract excerpt

SGLT2 inhibitors act to induce glucosuria and have been shown to be efficacious in the treatment of type II diabetes mellitus but have also been shown to positively affect cardiovascular conditions and some benefitting kidney function. SGLT2i have shown to be effective in more advanced conditions but may eventually be a treatment in more general metabolic dysfunction. Metabolic syndrome is a clinical diagnosis for...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d00d857c-9233-548e-b23e-a57bf261570e
DOI: 10.20944/preprints202204.0202.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

SGLT2 Inhibitors and Potential Applications in Treating Metabolic SyndromeDOI 10.20944/preprints202204.0202.v1Read

Development of SGLT1 and SGLT2 inhibitors.Semantic proximity Read

A Preclinical Model of Obesity-Independent Metabolic Syndrome for Studying the Effects of Novel Antidiabetic Therapy Beyond Glycemic ControlSemantic proximity Read

Extraglycemic effects of sodium glucose cotransporter 2 inhibitors with a systemic approach, from possibilities to certaintySemantic proximity Read

A Preclinical Model of Obesity-Independent Metabolic Syndrome for Studying the Effects of Novel Antidiabetic Therapy Beyond Glycemic ControlSemantic proximity Read

Preclinical Modeling of Metabolic Syndrome to Study the Pleiotropic Effects of Novel Antidiabetic Therapy Independent of ObesitySemantic proximity Read

Nonglycemic Effects of SGLT2 Inhibitors: Focus on Inflammation and MacrophagesSemantic proximity Read

Sodium-glucose co-transporter 2 Inhibitors Act Independently of <i>SGLT2</i> to Confer Benefit for Heart Failure with Reduced Ejection Fraction in MiceSemantic proximity Read

Efficacy and Safety of SGLT2 Inhibitors in the Treatment of Type 2 Diabetes: An Umbrella ReviewSemantic proximity Read

Hypertriglyceridemia-Causes, Significance, and Approaches to Therapy.Semantic proximity Read

SGLT2 Inhibitors Produce Cardiorenal Benefits by Promoting Adaptive Cellular Reprogramming to Induce a State of Fasting Mimicry: A Paradigm Shift in Understanding Their Mechanism of ActionSemantic proximity Read

CETP and SGLT2 inhibitor combination therapy improves glycemic controlSemantic proximity Read

Mouse Models with SGLT2 Mutations: Toward Understanding the Role of SGLT2 beyond Glucose Reabsorption.Semantic proximity Read